Neonatal Acute Liver Failure. Clin Perinatol 2020 Mar;47(1):25-39
Date
02/01/2020Pubmed ID
32000927DOI
10.1016/j.clp.2019.10.006Scopus ID
2-s2.0-85076843825 (requires institutional sign-in at Scopus site) 20 CitationsAbstract
Neonatal acute liver failure (NALF) is a rare disease with a few known primary causes: gestational alloimmune liver disease (GALD), viral infections, metabolic diseases, and ischemic injury. Many cases still do not have a known cause. Laboratory evaluation may suggest a diagnosis. Most of the known causes have disease-specific treatments that improve outcomes. Survival is improving with better knowledge about and treatment options for GALD; however, overall mortality for NALF is still 24%. Liver transplant remains an important option for neonates with an indeterminate cause of NALF and those who do not respond to established treatments.
Author List
Larson-Nath C, Vitola BEAuthor
Bernadette Vitola MD, MPH Professor in the Pediatrics department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
HumansInfant, Newborn
Liver Failure, Acute
Neonatal Screening
Prognosis
Rare Diseases









